Mark Bouris is a financial man. No biotech out there in his resume.
So he was meant to be a deal closer, and a popular face to get ADO some attention.
Neither of which has happened.
Glad he has moved on. Good for him I'm sure, better for us.
Would like to see a chairman with biotech or technology experience, many years of experience and a solid reputation in financial circles. Not for being a financial whiz(aka MB) but for someone who has delivered financial results.
But ADO is very small(still...argh) so the calibre we will attract is a little limited.
I just hope its not a Diasource person otherwise this whole thing reeks of a reverse takeover and we dont have any idea where that would lead. Possibly private...which is my worst fear...
nr chairman not to seek re-election at agm, page-21
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.22M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.9¢ | 2.7¢ | $17.68K | 634.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 541015 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 4693635 | 4 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| ADO (ASX) Chart |